-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Focus on Chemical Machinery Equipment Network ] It is reported that in order to meet the current needs of pharmaceutical production and increase workshop productivity and efficiency, pharmaceutical machinery companies will accelerate the construction of important projects in the new year.
The entire project is scheduled to be completed in the first half of 2022.
Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipmentThe entire project is scheduled to be completed in the first half of 2022.
The relevant person in charge of the company said that measures are currently being taken to speed up the progress of the project, so as to better meet my country's demand for relevant medical production equipment under the current situation.
In fact, this is just a microcosm of the expansion of demand in the pharmaceutical equipment market.
Pharmaceutical equipment belongs to the upstream of the pharmaceutical industry.
In the context of an aging population and consumption upgrades, the pharmaceutical market demand continues to expand, driving the growth of the pharmaceutical equipment market demand.
At the same time, pharmaceutical equipment is also facing challenges in terms of capacity upgrades, especially due to the impact of a special period in 2020, the disadvantages of traditional pharmaceutical machinery in terms of production capacity have become prominent, and it has become a trend to improve the level of equipment automation and intelligence.
Pharmaceutical equipment belongs to the upstream of the pharmaceutical industry.
In the context of an aging population and consumption upgrades, the pharmaceutical market demand continues to expand, driving the growth of the pharmaceutical equipment market demand.
At the same time, pharmaceutical equipment is also facing challenges in terms of capacity upgrades, especially due to the impact of a special period in 2020, the disadvantages of traditional pharmaceutical machinery in terms of production capacity have become prominent, and it has become a trend to improve the level of equipment automation and intelligence.
Facing new market opportunities, since 2020, many pharmaceutical machinery companies have been expanding production capacity and enhancing market competitiveness.
For example, Tofflon announced at the end of December 2020 that its wholly-owned subsidiary Tofflon Manufacturing plans to invest 500 million yuan to build a biopharmaceutical system equipment industrialization project, thereby expanding the company’s biological equipment manufacturing capacity and further enhancing the company’s biological engineering Overall solution capability.
For example, Tofflon announced at the end of December 2020 that its wholly-owned subsidiary Tofflon Manufacturing plans to invest 500 million yuan to build a biopharmaceutical system equipment industrialization project, thereby expanding the company’s biological equipment manufacturing capacity and further enhancing the company’s biological engineering Overall solution capability.
For another example, Canaan Technology issued an announcement on the evening of September 8, 2020, that the total amount of funds to be raised will not exceed 450 million yuan, which will be used for the construction of intelligent logistics system production center, pharmaceutical liquid dispensing system production center construction project, and pharmaceutical research and development service platform.
Upgrade and expansion projects and other aspects.
The company said that the implementation of this fundraising project will help the company to fully grasp market opportunities and expand the market scale of potential new products on the basis of consolidating its original business advantages.
Upgrade and expansion projects and other aspects.
The company said that the implementation of this fundraising project will help the company to fully grasp market opportunities and expand the market scale of potential new products on the basis of consolidating its original business advantages.
From the perspective of the overall upgrade direction, chemical is becoming the direction of the efforts of pharmaceutical equipment industry enterprises.
For a long time, due to my country’s weak pharmaceutical technology experience and low technological level, coupled with the relatively small scale of pharmaceutical machinery companies and low industry concentration, the development of the domestic pharmaceutical equipment market is very unstable, and the products are mainly concentrated in the low-end market.
Level and low-price competition are the mainstay.
In recent years, with the tightening of GMP requirements and the advancement of medical reform policies such as consistency evaluation, the quality of pharmaceuticals has been continuously improved, and the requirements for production equipment have also undergone significant changes, and pharmaceutical products have ushered in an increase in demand.
For a long time, due to my country’s weak pharmaceutical technology experience and low technological level, coupled with the relatively small scale of pharmaceutical machinery companies and low industry concentration, the development of the domestic pharmaceutical equipment market is very unstable, and the products are mainly concentrated in the low-end market.
Level and low-price competition are the mainstay.
In recent years, with the tightening of GMP requirements and the advancement of medical reform policies such as consistency evaluation, the quality of pharmaceuticals has been continuously improved, and the requirements for production equipment have also undergone significant changes, and pharmaceutical products have ushered in an increase in demand.
The industry generally believes that pharmaceutical mechanization has become a trend, and related policies also encourage the development of pharmaceutical machinery industry.
For example, in September 2020, my country’s four departments jointly issued the "Guiding Opinions on Expanding Strategic Emerging Industry Investment, Cultivating and Growing New Growth Pole Growth Pole", which proposed that the equipment manufacturing industry should be accelerated to make up for shortcomings.
Focus on supporting the production of equipment such as medical equipment and pharmaceutical equipment, and implement pilot demonstrations of smart manufacturing and smart construction.
The issuance of this blockbuster document will help the domestic pharmaceutical machinery industry to develop in the direction of chemistry.
For example, in September 2020, my country’s four departments jointly issued the "Guiding Opinions on Expanding Strategic Emerging Industry Investment, Cultivating and Growing New Growth Pole Growth Pole", which proposed that the equipment manufacturing industry should be accelerated to make up for shortcomings.
Focus on supporting the production of equipment such as medical equipment and pharmaceutical equipment, and implement pilot demonstrations of smart manufacturing and smart construction.
The issuance of this blockbuster document will help the domestic pharmaceutical machinery industry to develop in the direction of chemistry.
However, judging from the current market structure, domestically produced pharmaceutical machines are still facing a severe situation of "inadequate internal power and strong external enemies": among them, the main reason is the lack of independent innovation capabilities internally, and some parts and technologies rely on imports, which are obviously restricted.
In the case of people; externally, the competitiveness of domestic pharmaceutical machinery companies is weak, the technology gap is obvious, and the brand is not "loud" enough.
It can be seen that domestic pharmaceutical machinery is still facing huge challenges.
In the case of people; externally, the competitiveness of domestic pharmaceutical machinery companies is weak, the technology gap is obvious, and the brand is not "loud" enough.
It can be seen that domestic pharmaceutical machinery is still facing huge challenges.
After years of development, my country has become a veritable big country of pharmaceutical machinery, both in terms of production capacity and category, etc.
, but there is a long way to go to become a strong country in pharmaceutical machinery.
In the future, domestic pharmaceutical machinery companies need to pay attention to the training of professional talents and increase enterprises.
Invest in research and development, improve independent innovation capabilities, strengthen the development capabilities of key core components, develop high-tech and value-added pharmaceutical products, and improve the competitiveness of domestic pharmaceutical products.
, but there is a long way to go to become a strong country in pharmaceutical machinery.
In the future, domestic pharmaceutical machinery companies need to pay attention to the training of professional talents and increase enterprises.
Invest in research and development, improve independent innovation capabilities, strengthen the development capabilities of key core components, develop high-tech and value-added pharmaceutical products, and improve the competitiveness of domestic pharmaceutical products.
Original title: The demand or expansion of pharmaceutical production equipment, the development trend of the chemical industry